# Special Issue on Efficacy, Safety, and Immunogenicity of Vaccines Against Viruses: From Network Medicine to Clinical Experimentation

**Authors:** Pietro Hiram Guzzi, Jayanta Kumar Das, Marianna Milano

PMC · DOI: 10.3390/v18020165 · Viruses · 2026-01-27

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** influenza (MESH:D007251), injury to (MESH:D014947), hepatitis B (MESH:D006509), COVID-19 (MESH:D000086382)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Human immunodeficiency virus 1 (no rank) [taxon 11676], Puumala orthohantavirus [taxon 1980486], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945291/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945291/full.md

---
Source: https://tomesphere.com/paper/PMC12945291